This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
National Health Investors (NHI) Q2 FFO and Revenues Beat Estimates
by Zacks Equity Research
National Health Investors (NHI) delivered FFO and revenue surprises of 7.27% and 4.26%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Exploring Analyst Estimates for Medical Properties (MPW) Q2 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Medical Properties (MPW), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2024.
Medical Properties (MPW) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
The latest trading day saw Medical Properties (MPW) settling at $4.71, representing a +1.73% change from its previous close.
Park Hotels & Resorts (PK) Tops Q2 FFO Estimates
by Zacks Equity Research
Park Hotels & Resorts (PK) delivered FFO and revenue surprises of 3.17% and 1.29%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
MPW vs. SLG: Which Stock Is the Better Value Option?
by Zacks Equity Research
MPW vs. SLG: Which Stock Is the Better Value Option?
American Tower (AMT) Surpasses Q2 FFO and Revenue Estimates
by Zacks Equity Research
American Tower (AMT) delivered FFO and revenue surprises of 10.28% and 3.36%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
First Financial Bancorp (FFBC) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
First Financial (FFBC) delivered earnings and revenue surprises of 10.17% and 6.26%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Medical Properties (MPW) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
The latest trading day saw Medical Properties (MPW) settling at $5.20, representing a +1.56% change from its previous close.
Highwoods Properties (HIW) Q2 FFO Top Estimates
by Zacks Equity Research
Highwoods Properties (HIW) delivered FFO and revenue surprises of 8.89% and 1.96%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Medical Properties Trust, Inc. (MPW) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Medical Properties (MPW). This makes it worthwhile to examine what the stock has in store.
Why the Market Dipped But Medical Properties (MPW) Gained Today
by Zacks Equity Research
Medical Properties (MPW) reachead $4.80 at the closing of the latest trading day, reflecting a +1.91% change compared to its last close.
Medical Properties (MPW) Flat As Market Gains: What You Should Know
by Zacks Equity Research
Medical Properties (MPW) closed the most recent trading day at $4.52, making no change from the previous trading session.
Medical Properties Trust, Inc. (MPW) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching Medical Properties (MPW) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Medical Properties (MPW) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
In the closing of the recent trading day, Medical Properties (MPW) stood at $4.66, denoting a +0.22% change from the preceding trading day.
Medical Properties (MPW) Dips More Than Broader Market: What You Should Know
by Zacks Equity Research
In the closing of the recent trading day, Medical Properties (MPW) stood at $4.80, denoting a -0.21% change from the preceding trading day.
Medical Properties (MPW) Flat As Market Sinks: What You Should Know
by Zacks Equity Research
In the latest trading session, Medical Properties (MPW) closed at $4.81, marking no change from the previous day.
Here is What to Know Beyond Why Medical Properties Trust, Inc. (MPW) is a Trending Stock
by Zacks Equity Research
Medical Properties (MPW) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Is Trending Stock Medical Properties Trust, Inc. (MPW) a Buy Now?
by Zacks Equity Research
Zacks.com users have recently been watching Medical Properties (MPW) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Medical Properties Trust, Inc. (MPW) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Medical Properties (MPW) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Here's What Key Metrics Tell Us About Medical Properties (MPW) Q1 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for Medical Properties (MPW) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Medical Properties (MPW) Q1 FFO and Revenues Miss Estimates
by Zacks Equity Research
Medical Properties (MPW) delivered FFO and revenue surprises of -4% and 4.23%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Innovative Industrial Properties (IIPR) Q1 FFO and Revenues Miss Estimates
by Zacks Equity Research
Innovative Industrial Properties (IIPR) delivered FFO and revenue surprises of -2.64% and 5.27%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for Medical Properties (MPW) in Q1 Earnings?
by Zacks Equity Research
While Medical Properties' (MPW) Q1 earnings are likely to have benefited from the favorable healthcare industry trends, the high interest rate environment may have hurt it.
Global Net Lease (GNL) Matches Q1 FFO Estimates
by Zacks Equity Research
Global Net Lease (GNL) delivered FFO and revenue surprises of 0% and 0.97%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Factors to Impact Innovative Industrial's (IIPR) Q1 Earnings
by Zacks Equity Research
With the cannabis industry gaining prominence, Innovative Industrial's (IIPR) investments in such properties are likely to have aided its Q1 performance, though high expenses might have played a spoilsport.